Tag: Pembrolizumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Pembrolizumab

Purple Biotech Granted New U.S. Patent for NT219 in - GlobeNewswire

Added to Collection on: 2025-03-05 12:38:01

Tags for this article:

Cancer immunotherapy
Immune system
Biotechnology
Oncogenes
Antineoplastic drugs
Cetuximab
Epidermal growth factor receptor
Head and neck cancer
Pembrolizumab
Panitumumab
Checkpoint inhibitor
Tumor microenvironment
REHOVOT
Purple Biotech Ltd.
Israel

Click the tags to see associated articles and topics

View Article Details
Merkel Cell Carcinoma Market is Expected to Advance at a CAGR of 8.7% During the Study ...

Added to Collection on: 2025-03-06 23:48:38

Tags for this article:

Orphan drugs
Merkel-cell carcinoma
Cancer immunotherapy
Antineoplastic drugs
Avelumab
Pembrolizumab
Cancer
Merkel cell polyomavirus
Merus NV
Kymera Therapeutics
Phio Pharmaceuticals
Philogen

Click the tags to see associated articles and topics

View Article Details
PDS Biotech Launches First Phase 3 Trial for HPV16 Head and Neck Cancer Treatment

Added to Collection on: 2025-03-07 19:53:45

Tags for this article:

Cancer immunotherapy
Papillomavirus
Otorhinolaryngology
Antineoplastic drugs
Orphan drugs
Pembrolizumab
Human papillomavirus infection
Head and neck cancer
Checkpoint inhibitor
HPV-positive oropharyngeal cancer
Katharine Price
pds biotechnology corporation

Click the tags to see associated articles and topics

View Article Details
BioCity and MSD to evaluate cancer treatment combination in Phase I/II trial

Added to Collection on: 2025-03-15 05:23:27

Tags for this article:

Antineoplastic drugs
Biotechnology
Immunology
Cancer immunotherapy
Antibody-drug conjugate
Genetic engineering
Pembrolizumab

Click the tags to see associated articles and topics

View Article Details
Refractory Metastatic Melanoma Pipeline Report 2025, with Focus on BioNTech SE, Y-mAbs ...

Added to Collection on: 2025-03-20 17:51:01

Tags for this article:

Antineoplastic drugs
Cancer
Melanoma
Cancer immunotherapy
Cancer vaccine
Immunotherapy
Orphan drugs
Immunology
Pembrolizumab
Ipilimumab
ResearchAndMarkets.com

Click the tags to see associated articles and topics

View Article Details
Akamis Bio Announces Enrollment of First Patient in Phase 1b FORTRESS Trial of NG-350A ...

Added to Collection on: 2025-04-04 14:49:24

Tags for this article:

Antineoplastic drugs
Orphan drugs
Cancer
Biotechnology
Pembrolizumab
Colorectal cancer
Tumor microenvironment
Oncology
Enadenotucirev
Ng
Cambridge

Click the tags to see associated articles and topics

View Article Details
Gilead's Trodelvy, With Keytruda, Slows Disease Progression in Triple-Negative Breast Cancer

Added to Collection on: 2025-04-22 12:52:10

Tags for this article:

Antineoplastic drugs
Orphan drugs
Cancer immunotherapy
Ivonescimab
Triple-negative breast cancer
Antibody-drug conjugate
Sacituzumab govitecan
Vascular endothelial growth factor
Pembrolizumab
Non-small-cell lung cancer
Programmed cell death protein 1
Bispecific monoclonal antibody
Merck
Gilead

Click the tags to see associated articles and topics

View Article Details
FDA Approves Akeso's PD-1 Monoclonal Antibody for Recurrent or Metastatic Non ...

Added to Collection on: 2025-04-25 16:13:08

Tags for this article:

Lung cancer
Infectious causes of cancer
Orphan drugs
Angiogenesis inhibitors
Antineoplastic drugs
Nasopharyngeal carcinoma
Non-small-cell lung cancer
Ivonescimab
Head and neck cancer
Small-cell carcinoma
Nivolumab
Pembrolizumab

Click the tags to see associated articles and topics

View Article Details
Incyte Announces FDA Approval of Zynyz® (retifanlimab-dlwr) Making it the First and Only ...

Added to Collection on: 2025-05-16 09:08:49

Tags for this article:

Orphan drugs
Lung cancer
Infectious causes of cancer
Antineoplastic drugs
Anal cancer
Gastrointestinal cancer
Non-small-cell lung cancer
Small-cell carcinoma
Pembrolizumab
Treatment of lung cancer
Incyte Corporation
United States
Wilmington
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
FDA Approves Emrelis for High c-Met Protein Overexpressing NSCLC

Added to Collection on: 2025-05-16 14:31:38

Tags for this article:

Orphan drugs
Antineoplastic drugs
Lung cancer
Antibody-drug conjugates
Cancer immunotherapy
Non-small-cell lung cancer
Atezolizumab
Pembrolizumab
vedotin
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Book a Demo